ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 621322 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 621322; 2) Community: the network communities that were significantly associated with the response to NSC 621322; 3) Molecule: the relationships between components within communities and NSC 621322; 4) MDR: the compounds that were significantly associated with the NSC 621322.

NSC Compound Enrichment Correlation
NSC 692655 D-Homo-17a-aza-5-androsteno[17,16-c]pyrazol-3-yl,2'-(4-fluorophenyl)-, acetate 0.0273093708703115 0.0086636768
NSC 699095 Null 0.0273093708703115 0.26815629
NSC 707148 Card-20(22)-enolide, 3-[(6-deoxy-3-O-methyl-.beta.-D-galacto pyranosyl)oxy]-14-hydroxy-, (3.beta.,5.beta)- (9CI) 0.0273093708703115 0.22333803
NSC 717859 Null 0.0273093708703115 0.037575328
NSC 720379 Null 0.0273093708703115 0.22103311
NSC 724040 Null 0.0273093708703115 0.13819592
NSC 726973 Bis-{(5,6-dihydro-5,11-diketo-11H-indeno[1,2-c]isoquinoline) -6-ethylamino}ethane Bis(trifluoroacetate) 0.0273093708703115 0.032282772
NSC 727719 (-)-Leucascandrolide A 0.0273093708703115 0.020822303
NSC 72942 DL-Noformicin 0.0273093708703115 0.0044877962
NSC 729812 6-(3-Chloropropyl)-5,6-dihydro-8,9-methylenedioxy-5,11-dioxo -3-nitro-11H-indeno[1,2-c]isoquinoline 0.0273093708703115 -0.016394607
Total:83  Current:54    [First] [Prev] [Next] [Last]